| Diagnostic Modality . | N = 55 Necrosis Events . | . | . |
|---|---|---|---|
| . | n, % . | Toxicity Grade . | n, % . |
| MRI + clinical judgment | 7, 12.7% | Grade 1 (radiographic only) | 22, 40.0% |
| MRI perfusion/ spectroscopy | 31, 56.4% | Grade 2 (medical therapy required) | 23, 41.8% |
| MR perfusion | 7, 12.7% | Grade 3 (surgical therapy required) | 10, 18.2% |
| MR spectroscopy | 2, 3.6% | ||
| Surgical resection | 10, 18.2% |
| Diagnostic Modality . | N = 55 Necrosis Events . | . | . |
|---|---|---|---|
| . | n, % . | Toxicity Grade . | n, % . |
| MRI + clinical judgment | 7, 12.7% | Grade 1 (radiographic only) | 22, 40.0% |
| MRI perfusion/ spectroscopy | 31, 56.4% | Grade 2 (medical therapy required) | 23, 41.8% |
| MR perfusion | 7, 12.7% | Grade 3 (surgical therapy required) | 10, 18.2% |
| MR spectroscopy | 2, 3.6% | ||
| Surgical resection | 10, 18.2% |
| Diagnostic Modality . | N = 55 Necrosis Events . | . | . |
|---|---|---|---|
| . | n, % . | Toxicity Grade . | n, % . |
| MRI + clinical judgment | 7, 12.7% | Grade 1 (radiographic only) | 22, 40.0% |
| MRI perfusion/ spectroscopy | 31, 56.4% | Grade 2 (medical therapy required) | 23, 41.8% |
| MR perfusion | 7, 12.7% | Grade 3 (surgical therapy required) | 10, 18.2% |
| MR spectroscopy | 2, 3.6% | ||
| Surgical resection | 10, 18.2% |
| Diagnostic Modality . | N = 55 Necrosis Events . | . | . |
|---|---|---|---|
| . | n, % . | Toxicity Grade . | n, % . |
| MRI + clinical judgment | 7, 12.7% | Grade 1 (radiographic only) | 22, 40.0% |
| MRI perfusion/ spectroscopy | 31, 56.4% | Grade 2 (medical therapy required) | 23, 41.8% |
| MR perfusion | 7, 12.7% | Grade 3 (surgical therapy required) | 10, 18.2% |
| MR spectroscopy | 2, 3.6% | ||
| Surgical resection | 10, 18.2% |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
